| 67.82 1.25 (1.88%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 80.25  |
1-year : | 93.73 |
| Resists | First : | 68.7 |
Second : | 80.25 |
| Pivot price | 63.63 |
|||
| Supports | First : | 62.98 |
Second : | 59.43 |
| MAs | MA(5) : | 65.69 |
MA(20) : | 63.17 |
| MA(100) : | 59.14 |
MA(250) : | 57.37 |
|
| MACD | MACD : | 1.7 |
Signal : | 1.4 |
| %K %D | K(14,3) : | 86.1  |
D(3) : | 84.2 |
| RSI | RSI(14): 71.6 |
|||
| 52-week | High : | 68.7 | Low : | 50.45 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ UTMD ] has closed above the upper band by 5.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 70.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 68.79 - 69.05 | 69.05 - 69.25 |
| Low: | 65.75 - 66.07 | 66.07 - 66.32 |
| Close: | 67.34 - 67.83 | 67.83 - 68.23 |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN tool to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices through direct customer service and sales force, independent consultants, and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Sat, 21 Feb 2026
Utah Medical Products (NASDAQ:UTMD) Stock Price Passes Above 200 Day Moving Average - What's Next? - MarketBeat
Sun, 08 Feb 2026
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31 - Yahoo Finance
Wed, 04 Feb 2026
Utah Medical Products Is Quietly Crushing It – But Is UTMD Stock Still Worth the Hype? - AD HOC NEWS
Wed, 04 Feb 2026
Utah Medical Products raises quarterly dividend by 1.6% to $0.31 - Investing.com
Wed, 04 Feb 2026
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y - The Globe and Mail
Wed, 04 Feb 2026
Dividend rises 1.6% at Utah Medical, now $0.31 a share - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 3 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 7.1 (%) |
| Held by Institutions | 71.2 (%) |
| Shares Short | 99 (K) |
| Shares Short P.Month | 99 (K) |
| EPS | 3.48 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 37.29 |
| Profit Margin | 29.2 % |
| Operating Margin | 27 % |
| Return on Assets (ttm) | 5.8 % |
| Return on Equity (ttm) | 9.5 % |
| Qtrly Rev. Growth | -1.3 % |
| Gross Profit (p.s.) | 6.89 |
| Sales Per Share | 12.07 |
| EBITDA (p.s.) | 4.49 |
| Qtrly Earnings Growth | -6.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 19.48 |
| PEG Ratio | 0 |
| Price to Book value | 1.81 |
| Price to Sales | 5.61 |
| Price to Cash Flow | 0 |
| Dividend | 0.31 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|